Karen Jagoda

Empowered Patient Podcast

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: empoweredpatient.libsyn.com

Autor

Karen Jagoda

Kategoria

Health

Strona podcastu

empoweredpatient.libsyn.com

Ostatni odcinek

15 paź 2026

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Pobierz z Google Play Zainstaluj za darmo Android prawie 10 mln pobrań · ocena 4,8 iOS niedługo

Odcinki

Virtual Transitionist Model Reduces Complications after Acute Care Events with Dr. David Feldman Dimer Health 18.08.2026

Dr. David Feldman is the Chief Medical Officer at Dimer Health, a virtual care medical practice designed to improve patient outcomes during the critical 1-3 days following hospital discharge, outpatient surgery, or emergency room visits.  The company addresses the gap in post-acute care between hospital care and primary care follow-up by proactive monitoring, medication management, and pain contro...

Certified Drug Label Translations in 26 Languages for Limited English Proficient Patients with Sharon Blank RxTran TRANSCRIPT 17.08.2026

Sharon Blank , CEO of RxTran, highlights the value of certified translations of prescription dosing instructions in 26 languages to ensure that limited-English-proficient patients can understand dosing and medication risks.  The organization works with pharmacies to deliver translations created by native-speaking pharmacists rather than by automated systems or untrained interpreters. As this LEP p...

Certified Drug Label Translations in 26 Languages for Limited English Proficient Patients with Sharon Blank RxTran 17.08.2026

Sharon Blank , CEO of RxTran, highlights the value of certified translations of prescription dosing instructions in 26 languages to ensure that limited-English-proficient patients can understand dosing and medication risks.  The organization works with pharmacies to deliver translations created by native-speaking pharmacists rather than by automated systems or untrained interpreters. As this LEP p...

Using AI to Unify Healthcare HR Systems to Reduce Administrative Burden with Craig Ahrens Worki TRANSCRIPT 13.08.2026

Craig Ahrens is the CEO of Worki, a healthcare workforce management platform that aggregates fragmented HR records by unifying disparate data sources and deploying AI agents to streamline workflows. To address anxieties, the focus needs to be on reducing administrative burdens through intelligent scheduling, not on eliminating jobs. Transparency is key for employees in this integration of legacy s...

Using AI to Unify Healthcare HR Systems to Reduce Administrative Burden with Craig Ahrens Worki 13.08.2026

Craig Ahrens is the CEO of Worki, a healthcare workforce management platform that aggregates fragmented HR records by unifying disparate data sources and deploying AI agents to streamline workflows. To address anxieties, the focus needs to be on reducing administrative burdens through intelligent scheduling, not on eliminating jobs. Transparency is key for employees in this integration of legacy s...

Integrated Continuous Data-Driven Care for Severe Mental Illness with Sonia Garcia Amae Health TRANSCRIPT 12.08.2026

Sonia Garcia , Co-Founder and Chief Growth Officer at Amae Health, an integrated care company specializing in the treatment of severe mental illness that operates community-oriented clinics to deliver comprehensive psychiatry-led care. They provide continuity of care across multiple acuity levels, recognizing these conditions require long-term management. Amae is also advancing psychiatric care th...

Integrated Continuous Data-Driven Care for Severe Mental Illness with Sonia Garcia Amae Health 12.08.2026

Sonia Garcia , Co-Founder and Chief Growth Officer at Amae Health, an integrated care company specializing in the treatment of severe mental illness that operates community-oriented clinics to deliver comprehensive psychiatry-led care. They provide continuity of care across multiple acuity levels, recognizing these conditions require long-term management. Amae is also advancing psychiatric care th...

Expanding Advanced Lung Transplant Assessment and Utilization with Sarah Lowe XVIVO TRANSCRIPT 11.08.2026

Sarah Lowe , Global Clinical Operations Director at XVIVO, develops technologies to preserve, assess, and transport organs for transplantation. With advanced assessment of donor lungs, the mission is to evaluate marginal organs better to address the critical challenge that only 2 out of 10 available lungs are currently accepted for transplant. With their first in-house ex vivo lung perfusion progr...

Expanding Advanced Lung Transplant Assessment and Utilization with Sarah Lowe XVIVO 11.08.2026

Sarah Lowe , Global Clinical Operations Director at XVIVO, develops technologies to preserve, assess, and transport organs for transplantation. With advanced assessment of donor lungs, the mission is to evaluate marginal organs better to address the critical challenge that only 2 out of 10 available lungs are currently accepted for transplant. With their first in-house ex vivo lung perfusion progr...

Platform Targets Root Causes of Disease to Drive Drug Discovery with Vin Singh Bullfrog AI TRANSCRIPT 10.08.2026

Vin Singh , Founder, Chairman, and CEO of Bullfrog AI, is applying proprietary AI technology to drug development, with a focus on drug target discovery and phase three clinical trials. The company's platform is derived from the Johns Hopkins University Applied Physics Lab and is designed to pinpoint drug targets, identify the root causes of disease, and match patients to appropriate treatments bas...

Platform Targets Root Causes of Disease to Drive Drug Discovery with Vin Singh Bullfrog AI 10.08.2026

Vin Singh , Founder, Chairman, and CEO of Bullfrog AI, is applying proprietary AI technology to drug development, with a focus on drug target discovery and phase three clinical trials. The company's platform is derived from the Johns Hopkins University Applied Physics Lab and is designed to pinpoint drug targets, identify the root causes of disease, and match patients to appropriate treatments bas...

Addressing Social Drivers of Health to Improve Patient Outcomes with Dr. Greg Carroll ClinNEXUS TRANSCRIPT 10.08.2026

Dr. Greg Carroll, emergency physician and Co-Founder and CEO of ClinNEXUS,  a data-first healthcare company addressing social drivers of health i n underserv ed communities by breaking down data silos. Integrating clinical information with social, behavioral, and environmental factors and using AI to augment human care coordinators enables them to identify patient needs proactively and provide per...

Addressing Social Drivers of Health to Improve Patient Outcomes with Dr. Greg Carroll ClinNEXUS 10.08.2026

Dr. Greg Carroll, emergency physician and Co-Founder and CEO of ClinNEXUS,  a data-first healthcare company addressing social drivers of health i n underserv ed communities by breaking down data silos. Integrating clinical information with social, behavioral, and environmental factors and using AI to augment human care coordinators enables them to identify patient needs proactively and provide per...

Image-Based Digital Biomarkers Detected by AI Platform to Transform Drug Development and Clinical Care with Susan Wood VIDA TRANSCRIPT 06.08.2026

Susan Wood , CEO of VIDA, develops AI-driven imaging-based biomarkers that quantitatively measure biological processes and disease states using imaging modalities such as CT, MRI, PET, and ultrasound. Unlike traditional visual image analysis, VIDA's technology extracts approximately 25,000 measurements per imaging timepoint, enabling detection of therapeutic responses at the sub-millimeter level....

Image-Based Digital Biomarkers Detected by AI Platform to Transform Drug Development and Clinical Care with Susan Wood VIDA 06.08.2026

Susan Wood , CEO of VIDA, develops AI-driven imaging-based biomarkers that quantitatively measure biological processes and disease states using imaging modalities such as CT, MRI, PET, and ultrasound. Unlike traditional visual image analysis, VIDA's technology extracts approximately 25,000 measurements per imaging timepoint, enabling detection of therapeutic responses at the sub-millimeter level....

Clinician-Supervised Purpose-Built AI Bridges Behavioral Health Therapy Gaps with Luis Voloch Jimini Health TRANSCRIPT 05.08.2026

Luis Voloch , Co-Founder and CEO of Jimini Health, focuses on mental health through the Sage platform, which provides continuous AI support for patients while keeping clinicians informed and in control. The approach addresses the problem of patients turning to general-purpose AI for behavioral health support by offering a HIPAA-compliant, purpose-built alternative with proper safeguards and clinic...

Clinician-Supervised Purpose-Built AI Bridges Behavioral Health Therapy Gaps with Luis Voloch Jimini Health 05.08.2026

Luis Voloch , Co-Founder and CEO of Jimini Health, focuses on mental health through the Sage platform, which provides continuous AI support for patients while keeping clinicians informed and in control. The approach addresses the problem of patients turning to general-purpose AI for behavioral health support by offering a HIPAA-compliant, purpose-built alternative with proper safeguards and clinic...

Localized Immunotherapy by Direct Injection Treats Solid Tumors and Activates the Immune System with Lew Bender Intensity Therapeutics TRANSCRIPT 05.08.2026

Lew Bender , Founder and CEO of Intensity Therapeutics,  has developed a novel approach to treating solid tumors through direct intratumoral injection of existing chemotherapy drugs. The company uses a proprietary formulation containing a special molecule that makes water-based drugs soluble in fatty tissue, allowing cisplatin and vinblastine to penetrate tumor cells effectively. Beyond direct kil...

Localized Immunotherapy by Direct Injection Treats Solid Tumors and Activates the Immune System with Lew Bender Intensity Therapeutics 05.08.2026

Lew Bender , Founder and CEO of Intensity Therapeutics,  has developed a novel approach to treating solid tumors through direct intratumoral injection of existing chemotherapy drugs. The company uses a proprietary formulation containing a special molecule that makes water-based drugs soluble in fatty tissue, allowing cisplatin and vinblastine to penetrate tumor cells effectively. Beyond direct kil...

How Voice AI Agents Coordinate Healthcare and Improve Patient Access with Dr. Erin Palm Infinitus TRANSCRIPT 04.08.2026

Dr. Erin Palm , medical lead at Infinitus, specializes in agentic AI for healthcare, leveraging voice technology to facilitate actions and execute tasks on behalf of providers, payers, and patients to coordinate administrative functions and patient-facing applications. These agents can handle appointment booking, medication inquiries, and emergency triage within an environment with rigorous qualit...

How Voice AI Agents Coordinate Healthcare and Improve Patient Access with Dr. Erin Palm Infinitus 04.08.2026

Dr. Erin Palm , medical lead at Infinitus, specializes in agentic AI for healthcare, leveraging voice technology to facilitate actions and execute tasks on behalf of providers, payers, and patients to coordinate administrative functions and patient-facing applications. These agents can handle appointment booking, medication inquiries, and emergency triage within an environment with rigorous qualit...

Long-Acting Antibody Treatment for HIV/AIDS Patients with Jimmy Chang TaiMed Biologics TRANSCRIPT 03.08.2026

J immy Chang, Chairman and CEO of TaiMed Biologics,  is approaching critical unmet needs in HIV care, particularly for aging patients with comorbidities who face risks from drug-drug interactions with multiple medications. The company is advancing the next-generation antibodies designed for bimonthly injections and an alternative to daily oral medications, while minimizing enzymatic metabolism and...

Long-Acting Antibody Treatment for HIV/AIDS Patients with Jimmy Chang TaiMed Biologics 03.08.2026

J immy Chang, Chairman and CEO of TaiMed Biologics,  is approaching critical unmet needs in HIV care, particularly for aging patients with comorbidities who face risks from drug-drug interactions with multiple medications. The company is advancing the next-generation antibodies designed for bimonthly injections and an alternative to daily oral medications, while minimizing enzymatic metabolism and...

Popular Hospital Patient Experience Book Club Builds Empathy and Staff Connections with Dr. Katherine Hockman and Dilshad Marolia NYU Langone Health TRANSCRIPT 30.07.2026

Dr. Katherine Hockman , Director of the Division of Hospital Medicine at NYU Langone Health, and Dilshad Marolia , System Director of Hospitals and Regulatory and Policy Management at NYU Langone Health, are co-leaders of the Patient Experience Book Club for the hospital employees.  Operating since 2012, the program has grown from six books to 12 books per year, with sessions offered in-person and...

Popular Hospital Patient Experience Book Club Builds Empathy and Staff Connections with Dr. Katherine Hockman and Dilshad Marolia NYU Langone Health 30.07.2026

Dr. Katherine Hockman , Director of the Division of Hospital Medicine at NYU Langone Health, and Dilshad Marolia , System Director of Hospitals and Regulatory and Policy Management at NYU Langone Health, are co-leaders of the Patient Experience Book Club for the hospital employees.  Operating since 2012, the program has grown from six books to 12 books per year, with sessions offered in-person and...

Słuchaj podcastu Empowered Patient Podcast w Replaio

Radio i podcasty w jednej aplikacji - za darmo, bez zakładania konta. Zainstaluj już dziś i nie przegap premiery

Pobierz z Google Play

Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS